Por: Ars Technica Science December 02, 2023
Navigate Filter by topic Settings Front page layout Site theme - Dec 2, 2023 1:00 pm UTC / The protein structure of CAS, shown with nucleic acids bound. CRISPR—Clustered Regularly Interspaced Short Palindromic Repeats—is the microbial world’s answer to adaptive immunity. Bacteria don’t generate antibodies when they are invaded by a pathogen and then hold those antibodies in abeyance in case they encounter that same pathogen again, the... + full article
The Boston Globe USA Business March 01, 2023
A Boston biotech startup is developing a new class of gene editing technologies that could control how our genetic code is read without changing the code itself. Chroma Medicine, whose labs are in the Fenway neighborhood, announced Wednesday that it raised $135 million towards... + más
Boston startup Ascidian Therapeutics charts vision for therapies that ‘rewrite RNA’ | The Boston Globe
Scientists Have Reached a Key Milestone in Learning How to Reverse Aging | Time
The Boston Globe USA Business February 22, 2023
Moderna is aiming to build a gene editing franchise powered by some of the same technologies used in its COVID-19 vaccines. The Cambridge biotech company announced Wednesday that it will partner with Life Edit Therapeutics to develop potentially permanent treatments for rare... + más
Vor Biopharma says first patient given its gene editing therapy for leukemia is in remission | The Boston Globe
Opinion | The New York Times
Forbes USA Business January 24, 2023
Ginkgo Bioworks banner on the façade of the New York Stock Exchange building.Ginkgo Bioworks is getting ready for another year of disrupting the entire biotech industry model with its versatile menu of biology engineering services. As a full-stack synthetic biology service... + más
Ginkgo Bioworks buys two small biotech companies | The Boston Globe
Ginkgo is trying to detect future man-made biological threats | The Boston Globe
Ars Technica USA Science January 05, 2023
Navigate Filter by topic Settings Front page layout Site theme - Jan 5, 2023 12:45 pm UTC MARK GARLICK/SCIENCE PHOTO LIBRARY Share this story Gene therapy has had a long and bumpy history. Although researchers have made some notable and Despite these issues, experts say there... + más
First participant in test of custom gene editing therapy dies | The Boston Globe
The New York Times USA Opinion December 09, 2022
The parents of a 2-year-old girl write that their daughter “could die within the next year” because a genetic mutation is causing her heart to fail.“Time is quickly running out for me,” writes a man in his mid-30s whose DNA harbors a genetic mistake certain to destroy... + más
Justice Alito accused of being SCOTUS leaker after new report: Disgrace | Newsweek
Why would Mac Jones get a second opinion on his injury, and how common is that? | The Boston Globe
Business Insider USA Business November 09, 2022
Goldman Sachs promoted 80 people to partner status on Wednesday, marking the largest class since David Solomon took over as CEO in 2018.Twenty-three of the new members are women and seven identify as black — the highest ever figures in both cases, the company said. Nineteen... + más
Goldman Sachs insiders say they are concerned about CEO David Solomon's push to build his personal brand, pointing to staff help for his DJing and use of the firm's planes | Business Insider
Who's up and who's down in the latest Goldman Sachs restructuring under CEO David Solomon | Business Insider
The Boston Globe USA Business October 12, 2022
Competition is heating up among biotech startups building technologies that improve or expand upon what gene editing can do. While most of these firms are devising therapies that permanently modify DNA to treat, and potentially cure, genetic diseases, a growing number think that... + más
Tech insiders have a lot to say about the local startup scene. Most of it is good. | The Boston Globe
See the presentations that hot healthcare startups used to raise millions from top VCs | Business Insider
About iurex | Privacy Policy | Disclaimer |